Cargando…

Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx

OBJECTIVE: Mass drug administration (MDA) with azithromycin for trachoma elimination reduces nasopharyngeal carriage of Streptococcus pneumoniae in the short term. We evaluated S. pneumoniae carried in the nasopharynx before and after a round of azithromycin MDA to determine whether MDA was associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gladstone, Rebecca A., Bojang, Ebrima, Hart, John, Harding-Esch, Emma M., Mabey, David, Sillah, Ansumana, Bailey, Robin L., Burr, Sarah E., Roca, Anna, Bentley, Stephen D., Holland, Martin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203556/ https://www.ncbi.nlm.nih.gov/pubmed/32750538 http://dx.doi.org/10.1016/j.cmi.2020.07.039

Ejemplares similares

Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control
por: Bojang, Ebrima, et al.
Publicado: (2017)

Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia
por: Burr, Sarah E., et al.
Publicado: (2013)

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control
por: Burr, Sarah E, et al.
Publicado: (2014)

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?
por: Burr, Sarah E., et al.
Publicado: (2016)

Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
por: Harrison, Mark Andrew, et al.
Publicado: (2019)

Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2017)

Trachoma Prevalence and Associated Risk Factors in The Gambia and Tanzania: Baseline Results of a Cluster Randomised Controlled Trial
por: Harding-Esch, Emma M., et al.
Publicado: (2010)

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws
por: Marks, Michael, et al.
Publicado: (2015)

The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa
por: Last, Anna R., et al.
Publicado: (2017)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Does azithromycin given to women in labour decrease ocular bacterial infection in neonates? A double-blind, randomized trial
por: Burr, Sarah E., et al.
Publicado: (2017)

Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma
por: Ho, Derek K-H., et al.
Publicado: (2015)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities
por: Burton, Matthew J., et al.
Publicado: (2010)

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children
por: Pickering, Harry, et al.
Publicado: (2022)

Epidemiology and control of trachoma: systematic review
por: Hu, Victor H, et al.
Publicado: (2010)

Impact of Intrapartum Oral Azithromycin on the Acquired Macrolide Resistome of Infants’ Nasopharynx: A Randomized Controlled Trial
por: Bojang, Abdoulie, et al.
Publicado: (2020)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Harnessing photography and image recognition technology to aid in the elimination of trachoma
por: Jimenez, Cristina, et al.
Publicado: (2022)

Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study
por: Last, Anna, et al.
Publicado: (2017)

The utility of serology for elimination surveillance of trachoma
por: Pinsent, Amy, et al.
Publicado: (2018)

Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
por: Marks, M, et al.
Publicado: (2016)

Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma
por: Marks, Michael, et al.
Publicado: (2016)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies
por: Migchelsen, Stephanie J., et al.
Publicado: (2017)

Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia
por: Ebert, Caleb D., et al.
Publicado: (2019)

To eliminate trachoma: Azithromycin mass drug administration coverage and associated factors among adults in Goro district, Southeast Ethiopia
por: Feyisa, Tadele, et al.
Publicado: (2022)

When Can Antibiotic Treatments for Trachoma Be Discontinued? Graduating Communities in Three African Countries
por: Ray, Kathryn J., et al.
Publicado: (2009)

A Cross-Sectional Study of ‘Yaws’ in Districts of Ghana Which Have Previously Undertaken Azithromycin Mass Drug Administration for Trachoma Control
por: Ghinai, Rosanna, et al.
Publicado: (2015)

An outbreak of acute haemorrhagic conjunctivitis associated with coxsackievirus A24 variant in The Gambia, West Africa
por: Burr, Sarah E., et al.
Publicado: (2017)

Elimination of Active Trachoma after Two Topical Mass Treatments with Azithromycin 1.5% Eye Drops
por: Amza, Abdou, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_roitukvo6b4ffc4mff7dol219q